Effects of intermittent theta-burst stimulation on cognition and glymphatic system activity in mild cognitive impairment and very mild Alzheimer's disease: a randomized controlled trial.
Cheng-Chang Yang, Ko-Yen Huang, Jung-Lung Hsu and 3 others
PMID 41013466WHAT IT FOUND
Active brain stimulation did not improve cognition immediately or change glymphatic clearance markers.
However, cognitive scores improved significantly four weeks after treatment ended. This delayed benefit suggests monitoring patients for several weeks post-intervention rather than expecting immediate results.
Key findings
01No significant difference in MMSE scores between active and sham groups at the end of the two-week intervention period.
02Participants receiving active stimulation showed significant improvement in MMSE scores at week 6 compared to baseline.
03No significant changes were observed in the ALPS index, a measure of glymphatic system activity, at any time point.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
High dropout rate in the control group (17 of 30 did not complete the 6-week follow-up), which may bias the comparison. The study relied on symptomatic clinical diagnosis for Alzheimer's disease rather than biomarker confirmation, which may affect the precision of the participant population. The ALPS index is a specific imaging measure that may not fully capture regional glymphatic changes, limiting conclusions about the mechanism of action. The sample size was relatively small (60 participants), and the study was single-center, requiring validation in larger multicenter trials.
Declared interests
Funded by the Ministry of Science and Technology, Taiwan, and Taipei Medical University. No commercial conflicts of interest were reported.
The easy way to misread this
Do not conclude that iTBS causes immediate cognitive improvement. The primary analysis showed no difference between active and sham groups at the end of the treatment period. The benefit observed was delayed, appearing four weeks after stimulation stopped, and the mechanism involving glymphatic clearance was not supported by the data.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →